The BioMelbourne Network and EY present – The Future of Health

The health sector in Australia is seeing a once in a lifetime transformation. An explosion in big data and mobile health technologies is enabling real-time information creation and analysis. Companies beyond health care as traditionally defined are entering the market, providing new sources of competition and partnering.

These trends are starting to drive a fundamentally different approach for consumers, moving beyond the delivery of health care to the management of health. Players need to be predictive, preemptive, preventative and participatory to remain relevant on a disrupted playing field in 2016.

EY Global Pharmaceutical Sector Leader, Patrick Flochel will host a panel discussion considering:

• Cost, quality and access challenges: how will these continue to spur global healthcare reform, and what is the likely impact to Australian players?
• Health care has entered the era of big data: how can Australian players capitalise on this opportunity, and prepare for the risks?
• Changing regulations and compliance: conducting business in Europe and the US

Panel Speakers:

Ms Dale Fisher, CEO of Peter MacCallum Cancer Centre

Dale Fisher is Chief Executive of the Peter MacCallum Cancer Centre, Australia’s only public hospital solely dedicated to cancer treatment, research and education and home to Australia’s largest cancer research program. Dale led the relocation of Peter Mac’s East Melbourne site to its new home in Parkville in 2016, as part of the $1.1 billion Victorian Comprehensive Cancer Centre (VCCC) Project.

Prior to joining Peter Mac, Dale was Chief Executive of The Royal Women’s Hospital for nine years. In recognition of her achievements in leadership and promoting excellence in women’s health to the Victorian community, Dale was inducted into the Victorian Honour Roll of Women in 2011 as part of the centenary celebrations for International Women’s Day.

In October 2013, Dale’s many roles as a strategic and educational leader were again recognised when she was honoured as one of the Australian Financial Review’s 100 Women of Influence.

Dale is a Board member of the Victorian Comprehensive Cancer Centre; the Committee for Melbourne and of the Centre for Workplace Leadership Advisory Board; and is an Associate Fellow of the Australian College of Health Service Executives. In March 2016 Dale was appointed as Adjunct Professor in the School of Public Health and Preventative Medicine, Monash University.

Dr Megan Robertson, Director of Research, St Vincent’s Hospital Melbourne

Megan took up the role as Director of Research at St Vincent’s Hospital Melbourne in April 2014, moving from the inaugural Executive Director of Research at Epworth Healthcare. Megan studied Medicine at University of Melbourne and trained as an intensive care specialist with postgraduate qualifications in internal medicine, anaesthesia and intensive care medicine. She has worked clinically in both the public and private health sectors and has extensive experience in clinical research and education.

 

Dr Priscilla Rogers, IBM Senior Manager, Cognitive Health & Life Sciences Research

Priscilla Rogers is the Senior Manager of the Cognitive Health & Life Sciences Research team at IBM Research Australia, where she leads a large, multi-disciplinary team in the area of data-driven healthcare. In her role, she is responsible for defining and driving the research agenda to drive next generation technologies into the market.

Priscilla is passionate about the convergence of technology and health, and the transformative impact it can have on the sector, with multiple years experience in the health sector. Her passion for healthcare and life sciences research began when she undertook a PhD in Engineering at Monash University, specialising in the exploitation of micro and nanoscale phenomena for diagnostic and drug discovery applications.

Panel Host:

EY’s Tokyo-based Global Pharmaceutical Sector Leader Patrick Flochel:

“Our biggest challenge today is: how can we redesign global health systems to be efficient and sustainable? How can the private sector, government and agile entrepreneurs combine resources and expertise to develop health ecosystems of the future?”

Patrick has held a global role for 20 years, the past 12 of which have been in life sciences, currently leading the EY relationship with one of the largest pharma companies globally. The Life Sciences practice is primarily based in the US and Europe with major growth plans for Asia (Singapore, China, Japan), and consists of around 3500 people worldwide.

Patrick sits on the sector leadership team and participates in the construction of EY’s point of view and strategic-level ideas about the evolution of the life sciences industry. He frequently speaks at global events and contributes to industry articles in the trade and general press.

Date: Wednesday 31st August, 2016
Time: 4:45pm registration for 5:00pm – 6:00pm followed by a networking session
Venue: EY, 8 Exhibition Street, Melbourne 3000, Victoria, Australia

Members – $65
Non-Members – $130
(Prices include GST)

To check if your organisation is a member click here

Who should attend?

Senior executives and decision makers, especially those with an interest in global commercialisation strategy, regulatory, reimbursement, health economics, data analytics and future innovation trends.

Hosted by:

 

 

EY is a leading global provider of assurance, tax, transaction and advisory services to the fife sciences sector. Our Global Life Sciences Centre brings together a worldwide network of more than 7,000 life science sector advisory professionals to anticipate trends, identify opportunities and implications and develop points of view on responding to critical issues. We can help you navigate your way forward and achieve success in the new ecosystem.